These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15701085)

  • 1. Expression of the bcl-6 and MUM1/IRF4 proteins correlate with overall and disease-specific survival in patients with primary cutaneous large B-cell lymphoma: a tissue microarray study.
    Sundram U; Kim Y; Mraz-Gernhard S; Hoppe R; Natkunam Y; Kohler S
    J Cutan Pathol; 2005 Mar; 32(3):227-34. PubMed ID: 15701085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary cutaneous large B-cell lymphoma of the leg: histogenetic analysis of a controversial clinicopathologic entity.
    Paulli M; Viglio A; Vivenza D; Capello D; Rossi D; Riboni R; Lucioni M; Incardona P; Boveri E; Bellosta M; Orlandi E; Borroni G; Lazzarino M; Berti E; Alessi E; Magrini U; Gaidano G
    Hum Pathol; 2002 Sep; 33(9):937-43. PubMed ID: 12378521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of B-cell transcription factors in primary cutaneous B-cell lymphoma.
    Hoefnagel JJ; Mulder MM; Dreef E; Jansen PM; Pals ST; Meijer CJ; Willemze R; Vermeer MH
    Mod Pathol; 2006 Sep; 19(9):1270-6. PubMed ID: 16778825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical profiling based on Bcl-2, CD10 and MUM1 expression improves risk stratification in patients with primary nodal diffuse large B cell lymphoma.
    Muris JJ; Meijer CJ; Vos W; van Krieken JH; Jiwa NM; Ossenkoppele GJ; Oudejans JJ
    J Pathol; 2006 Apr; 208(5):714-23. PubMed ID: 16400625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of CD10, BCL-6 and multiple myeloma-1 expression in diffuse large B-cell lymphomas in Malaysia.
    Peh SC; Gan GG; Lee LK; Eow GI
    Pathol Int; 2008 Sep; 58(9):572-9. PubMed ID: 18801072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2, Bcl-6 and CD10 expression in cutaneous B-cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance.
    Hoefnagel JJ; Vermeer MH; Jansen PM; Fleuren GJ; Meijer CJ; Willemze R
    Br J Dermatol; 2003 Dec; 149(6):1183-91. PubMed ID: 14674895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Gastrointestinal B-cell lymphoma: a morphologic and immunohistochemical study of 194 cases].
    He S; Guo Y; Bei CF; Dai YZ; Zhu DB; Li CS; Zhu XH; LE MZ
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):814-8. PubMed ID: 21215096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of germinal center B-cell lymphoma in archival specimens: critical evaluation of Bcl-6 protein expression in diffuse large B-cell lymphoma of the tonsil.
    Ree HJ; Ohsima K; Aozasa K; Takeuchi K; Kim CW; Yang WI; Huh JY; Lee SS; Ko YH; Kwon MS; Cho EY; Choi YL; Rhee JC; Kikuchi M; Mori S
    Hum Pathol; 2003 Jun; 34(6):610-6. PubMed ID: 12827616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary cutaneous diffuse large B-cell lymphoma, leg type: clinicopathologic features and prognostic analysis in 60 cases.
    Grange F; Beylot-Barry M; Courville P; Maubec E; Bagot M; Vergier B; Souteyrand P; Machet L; Dalac S; Esteve E; Templier I; Delaporte E; Avril MF; Robert C; Dalle S; Laroche L; Delaunay M; Joly P; Wechsler J; Petrella T
    Arch Dermatol; 2007 Sep; 143(9):1144-50. PubMed ID: 17875875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of bcl-6, CD10 and CD38 immunoreactivity in stage I-II gastric lymphomas: identification of a subset of CD10+ large B-cell lymphomas with a favorable outcome.
    Ponzoni M; Ferreri AJ; Pruneri G; Pozzi B; Dell'Oro S; Pigni A; Pinotti G; Villa E; Freschi M; Viale G; Capella C
    Int J Cancer; 2003 Aug; 106(2):288-91. PubMed ID: 12800208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of Bcl-6 and CD10 in diffuse large B-cell lymphomas: significance of Bcl-6 expression patterns in identifying germinal center B-cell lymphoma.
    Ree HJ; Yang WI; Kim CW; Huh J; Lee SS; Cho EY; Ko YH; Charney D
    Hum Pathol; 2001 Sep; 32(9):954-62. PubMed ID: 11567225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New prognostic relevant factors in primary cutaneous diffuse large B-cell lymphomas.
    Hallermann C; Niermann C; Fischer RJ; Schulze HJ
    J Am Acad Dermatol; 2007 Apr; 56(4):588-97. PubMed ID: 17289214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary cutaneous diffuse large B-cell lymphoma, NOS and leg type: Clinical, morphologic and prognostic differences.
    Felcht M; Klemke CD; Nicolay JP; Weiss C; Assaf C; Wobser M; Schlaak M; Hillen U; Moritz R; Tantcheva-Poor I; Nashan D; Beyer M; Dippel E; Müller CSL; Sachse MM; Meiss F; Géraud C; Marx A; Goerdt S; Geissinger E; Kempf W
    J Dtsch Dermatol Ges; 2019 Mar; 17(3):275-285. PubMed ID: 30851152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary breast diffuse large B-cell lymphoma shows a non-germinal center B-cell phenotype.
    Yoshida S; Nakamura N; Sasaki Y; Yoshida S; Yasuda M; Sagara H; Ohtake T; Takenoshita S; Abe M
    Mod Pathol; 2005 Mar; 18(3):398-405. PubMed ID: 15492762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct.
    Matolcsy A; Chadburn A; Knowles DM
    Am J Pathol; 1995 Jul; 147(1):207-16. PubMed ID: 7541611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immunophenotypic and molecular study of primary large B-cell lymphoma of bone.
    Huebner-Chan D; Fernandes B; Yang G; Lim MS
    Mod Pathol; 2001 Oct; 14(10):1000-7. PubMed ID: 11598170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous large B-cell lymphoma: the relation between morphology, clinical presentation, immunohistochemical markers, and survival.
    Fernández-Vázquez A; Rodríguez-Peralto JL; Martínez MA; Platón EM; Algara P; Camacho FI; López-Ríos F; Zarco C; Sánchez-Yus E; Fresno MF; Barthe L; Aliaga A; Fraga M; Forteza J; Oliva H; Piris MA
    Am J Surg Pathol; 2001 Mar; 25(3):307-15. PubMed ID: 11224600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p63 protein expression in high risk diffuse large B-cell lymphoma.
    Hallack Neto AE; Siqueira SA; Dulley FL; Ruiz MA; Chamone DA; Pereira J
    J Clin Pathol; 2009 Jan; 62(1):77-9. PubMed ID: 19103865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of diffuse large B cell lymphomas in rheumatoid arthritis.
    Baecklund E; Backlin C; Iliadou A; Granath F; Ekbom A; Amini RM; Feltelius N; Enblad G; Sundström C; Klareskog L; Askling J; Rosenquist R
    Arthritis Rheum; 2006 Dec; 54(12):3774-81. PubMed ID: 17133544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. bcl-2 protein expression in primary cutaneous large B-cell lymphoma is site-related.
    Geelen FA; Vermeer MH; Meijer CJ; Van der Putte SC; Kerkhof E; Kluin PM; Willemze R
    J Clin Oncol; 1998 Jun; 16(6):2080-5. PubMed ID: 9626207
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.